Governance · Policy · Dockets

The AI Public Pulse — Thursday, May 14, 2026

an AI Public Interest broadcast · daily
Shaping AI to serve the future. Keeping the public pulse.
▶ Watch this broadcast on YouTube — https://youtu.be/16DHJFp9UoE
// Open for public comment
national UK comment open rfi consultation

Growing up in the online world: a national consultation

We are consulting on further measures to prepare children for the future in an age of rapid technological change. This includes potential age restrictions on social media and other services such as gaming sites and AI chatbots, restrictions on addictive design features and risky functionalities, and better support for parents and families.

Comment close 2026-05-26 (12 days)
us federal agency US comment open other

AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information

The Food and Drug Administration (FDA or the Agency) is issuing this request for information to solicit input on a proposed pilot program to assess how artificial intelligence (AI)-enabled technologies can improve efficiency, speed, and quality of decision- making in early phase clinical trials. Early-phase clinical trials represent a critical bottleneck in drug development, often characterized by high uncertainty, limited patient populations, and inefficient decision- making processes. This pilot program aims to explore how advances in AI and data science can improve trial efficiency, enhance safety monitoring, facilitate dose selection decisions, and enable more informed early go/no-go decisions (e.g., a regulatory decision as to whether a Phase 1 study may proceed) while maintaining FDA's rigorous scientific and regulatory standards and promoting trustworthy AI systems. The pilot program will be guided by principles aligned with the National Institute of Standards and Technology (NIST) AI Risk Management Framework (AI RMF).

Comment close 2026-05-29 (15 days)
// Recently decided / in motion
us state US-OH pre decision legislation

Regards AI-generated products, AI-systems acting as humans

Ohio House Bill 813 would require AI-generated content to carry distinctive watermarks and mandate disclosure when AI systems act as or emulate humans. The bill includes civil penalties of $2,500-$10,000 per violation, with enforcement by the state attorney general and private right of action for aggrieved parties.

us federal agency US monitoring other

CAISI Issues Request for Information About Securing AI Agent Systems

The Center for AI Standards and Innovation (CAISI) at NIST has issued a Request for Information seeking input on security practices for AI agent systems—AI systems capable of taking autonomous actions that impact real-world environments. The RFI focuses on novel security risks from machine learning models, including adversarial attacks, backdoor vulnerabilities, and misaligned objectives. Comments are due March 9, 2026.

national UK comment closed rfi consultation

Copyright and Artificial Intelligence

This consultation seeks views on how the government can ensure the UK’s legal framework for AI and copyright supports the UK creative industries and AI sector together.

us federal agency US monitoring other

Announcing the AI Agent Standards Initiative for Interoperable and Secure Innovation

The Initiative will ensure that the next generation of AI is widely adopted with confidence, can function securely on behalf of its users, and can interoperate smoothly across the digital ecosystem.

us state US-CO pre decision legislation

Conversational Artificial Intelligence Service Operator Requirements

Colorado's HB1263 proposes requirements for conversational artificial intelligence service operators. The bill was announced on May 11, 2026, and is currently in pre-decision status in the Colorado legislature.

us state US-CO pre decision legislation

Psychotherapy Artificial Intelligence Restrictions

Colorado House Bill 1195 (2026) would establish restrictions on artificial intelligence use in psychotherapy services. The bill is currently in pre-decision status, having been announced on May 11, 2026. No decision or effective dates have been set.